New tech aims to take the guesswork out of muscle pain diagnosis
NCT ID NCT05793086
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This observational study tests three non-invasive technologies—ultrasound, electrical impedance, and nerve excitability tests—to see if they can reliably diagnose myofascial pain syndrome. Researchers will compare results from 90 people with and without the condition. The goal is to find objective biomarkers that could improve diagnosis and treatment planning.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better, more objective ways to diagnose myofascial pain, replacing subjective assessments.
- What could go wrong
- This is an early observational study, not a treatment trial. The tests may not prove accurate enough for routine clinical use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOFASCIAL PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple tape unlock relief from muscle pain?
- Can botox beat ibuprofen for jaw pain from teeth grinding?
- Ultrasound reveals how jaw pain treatments change muscles
- Can a few therapy sessions ease jaw pain and improve sleep?
- Baking soda boost: could a kitchen staple improve pain injections?
- Laser beats shockwave for neck pain in new study